Passage BioPASG
13F holders, Q1 2026 (March 31)35holders +5
9new positions
6sold out
1famous investor
$7.77avg. 13F price*
At the end of Q1 2026, 35 institutions reported holding Passage Bio Inc. (PASG) in their 13F filings, up 5 from Q4 2025. 9 opened new positions and 6 sold out. The largest holders were Lynx1 Capital Management LP ($4.9M), Vestal Point Capital, LP ($2.4M) and Renaissance Technologies ($1.0M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Passage Bio Inc.
- CUSIP
- 702712209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $1.2M |
| Exits | 6 | $770K |
All 13F filers, Q4 2025 → Q1 2026: 264,866 shares bought and 67,238 shares sold, net +197,628 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Lynx1 Capital Management LP | 0.77% | No change | 623,704 | $4.9M |
| Vestal Point Capital, LP | 0.07% | No change | 305,000 | $2.4M |
| Renaissance Technologies | 0.00% | Add +22.5% | 133,612 | $1.0M |
| Eversept Partners, LP | 0.07% | Add +4.2% | 131,581 | $1.0M |
| Vanguard Capital Management LLC | 0.00% | — | 113,964 | $895K |
| Yiheng Capital Management, L.P. | 0.29% | Add +151.0% | 86,097 | $676K |
| Ikarian Capital, LLC | 0.08% | New | 68,124 | $535K |
| Erste Asset Management GmbH | 0.00% | No change | 85,262 | $527K |
| Geode Capital Management, LLC | 0.00% | Add +31.8% | 41,380 | $325K |
| BlackRock, Inc. | 0.00% | Reduce -1.1% | 28,595 | $224K |
| UBS Group AG | 0.00% | Add +1807.1% | 27,501 | $216K |
| Acadian Asset Management LLC | 0.00% | No change | 24,196 | $189K |
| Verdad Advisers, LP | 0.20% | New | 22,128 | $174K |
| Diadema Partners LP | 0.06% | New | 19,530 | $153K |
| Boothbay Fund Management, LLC | 0.00% | New | 18,871 | $148K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 17,049 | $134K |
| XTX Topco Ltd | 0.00% | New | 12,627 | $99K |
| Fiduciary Trust Co | 0.00% | No change | 10,750 | $84K |
| Persistent Asset Partners Ltd | 0.02% | New | 4,955 | $39K |
| Morgan Stanley | 0.00% | Reduce -38.0% | 2,650 | $21K |
| Rockefeller Capital Management L.P. | 0.00% | Add +60.0% | 800 | $6K |
| Vanguard Global Advisers, LLC | 0.00% | — | 638 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 502 | $4K |
| Barclays PLC | 0.00% | No change | 212 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -12.7% | 124 | $973 |
| Wells Fargo & Company | 0.00% | New | 115 | $903 |
| Parallel Advisors, LLC | 0.00% | No change | 16 | $126 |
| Osaic Holdings, Inc. | 0.00% | Reduce -25.0% | 15 | $117 |
| BNP Paribas Financial Markets | 0.00% | No change | 12 | $94 |
| LRI Investments, LLC | 0.00% | No change | 12 | $94 |
| JPMorgan Chase & Co. | 0.00% | No change | 15 | $93 |
| Harbour Investments, Inc. | 0.00% | No change | 3 | $24 |
| Cwm, LLC | 0.00% | No change | 1 | $8 |
| Royal Bank of Canada | 0.00% | New | 2 | $0 |
| Tsfg, LLC | 0.00% | No change | 5 | $0 |
"% of holder's portfolio" is PASG's weight in each manager's 13F, not the share of Passage Bio Inc. the manager owns.